Mark Bodmer Evelo Biosciences, Inc. (EVLO) insider trading activity

Mark Bodmer is CSO, President of R&D of Evelo Biosciences, Inc.. Currently has a direct ownership of 25,732 shares of EVLO, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 3,163 shares (Common Stock) at a price of $0.33 per share, resulting in proceeds of $1,043. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.7K

0% 3M change

0% 12M change

Total Value Held $0

Mark Bodmer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Open market or private sale	$1,043 $0.33 p/Share	3,163 Reduced 10.95%	25,732 Common Stock
Nov 07 2023	BUY Exercise of conversion of derivative security	-	6,625 Added 18.65%	28,895 Common Stock
Nov 02 2023	SELL Open market or private sale	$2,261 $0.33 p/Share	6,854 Reduced 23.53%	22,270 Common Stock
Nov 01 2023	BUY Exercise of conversion of derivative security	-	12,500 Added 30.03%	29,124 Common Stock
Aug 08 2023	SELL Open market or private sale	$29,747 $9.51 p/Share	3,128 Reduced 15.84%	16,624 Common Stock
Aug 07 2023	BUY Exercise of conversion of derivative security	-	6,625 Added 25.12%	19,752 Common Stock
May 23 2023	SELL Open market or private sale	$3,159 $0.14 p/Share	22,571 Reduced 7.92%	262,557 Common Stock
May 08 2023	SELL Open market or private sale	$8,841 $0.13 p/Share	68,014 Reduced 19.26%	285,128 Common Stock
May 07 2023	BUY Exercise of conversion of derivative security	-	132,500 Added 27.28%	353,142 Common Stock

Mark Bodmer

CSO, President of R&D

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EVLO shares.

Notify only if

Value

Insider Trading

Get notified when an Evelo Biosciences, Inc. insider buys or sells EVLO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Evelo Biosciences, Inc.

Track Activities on EVLO

Account